Journal article
Review article: the future of microbiome-based therapeutics
EL Gulliver, RB Young, M Chonwerawong, GL D'Adamo, T Thomason, JT Widdop, EL Rutten, V Rossetto Marcelino, RV Bryant, SP Costello, CL O'Brien, GL Hold, EM Giles, SC Forster
Alimentary Pharmacology and Therapeutics | WILEY | Published : 2022
DOI: 10.1111/apt.17049
Abstract
Background: From consumption of fermented foods and probiotics to emerging applications of faecal microbiota transplantation, the health benefit of manipulating the human microbiota has been exploited for millennia. Despite this history, recent technological advances are unlocking the capacity for targeted microbial manipulation as a novel therapeutic. Aim: This review summarises the current developments in microbiome-based medicines and provides insight into the next steps required for therapeutic development. Methods: Here we review current and emerging approaches and assess the capabilities and weaknesses of these technologies to provide safe and effective clinical interventions. Key lite..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
Australian Research Council, Grant/Award Number: DP190101504; Victorian Government